Client News

CureVac and Rentschler Biopharma Ramp up Manufacturing of COVID-19 Vaccine, CVnCoV

AiCuris changes its legal form: AiCuris Anti-infective Cures GmbH becomes AiCuris AG

RedHill Biopharma Announces Positive DSMB Futility Review for Phase 2/3 COVID-19 Study of Opaganib

Marinomed Biotech AG announces preliminary revenues and confirms outlook for 2020

RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo Pharmaceuticals

XPhyto announces drug formulation strategy and 2021 milestones

CatalYm GmbH: CatalYm Starts First-in-Human Phase I Clinical Trial with GDF-15 Neutralizing Antibody CTL-002 to Treat Patients with Checkpoint-Inhibitor Refractory Cancer

Adocia Announces Positive Clinical Results Confirming the Ultra-Rapid Profile of a BioChaperone® Lispro Formulation Containing Insulin from Partner Tonghua Dongbao

Newron completes enrollment of explanatory safety and efficacy study with evenamide in schizophrenia patients

Secarna Pharmaceuticals: Data published in Molecular Diagnostics & Therapy demonstrate how Secarna’s powerful bioinformatics generate improved LNA-modified antisense oligonucleotide therapies